Skip Navigation


European Heart Journal Advance Access originally published online on June 21, 2006
European Heart Journal 2006 27(14):1637-1639; doi:10.1093/eurheartj/ehl118
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/14/1637    most recent
ehl118v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kaski, J. C.
Right arrow Articles by Holt, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaski, J. C.
Right arrow Articles by Holt, D. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Pregnancy-associated plasma protein-A and cardiovascular risk

Juan Carlos Kaski* and David W. Holt

Division of Cardiac and Vascular Sciences, St George's, University of London, Cranmer Terrace, London SW17 0RE, UK

* Corresponding author. Tel: +44 20 8725 5901; fax: +44 20 8725 3328. E-mail address: jkaski@sgul.ac.uk

This editorial refers to ‘Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina’{dagger} by A.A. Elesber et al., on page 1678

The first 150 words of the full text of this article appear below.

Coronary artery disease (CAD) progression leading to acute coronary syndrome (ACS) is a rather unpredictable phenomenon. Clinicians currently depend on relatively crude risk scores to identify individuals at risk of developing serious cardiovascular events. Conventional risk factors are able to single out only a proportion of those individuals at a high risk of developing fatal cardiac events. The fact that both atherogenesis and atherosclerotic cardiovascular disease progression are directly linked to inflammatory mechanisms has generated interest among scientists as to the potential role of inflammatory molecules as markers of cardiovascular risk. C-reactive protein, a marker of inflammation, has been shown to add value to the predictive ability of conventional risk factors. However, given the complexity of the mechanisms responsible for both disease progression and acute events, it is unlikely that a single molecule can provide clinicians with an accurate prediction of cardiovascular risk. Current markers, including C-reactive protein, are non-specific . . . [Full Text of this Article]

PAPP-A: pathogenic mechanism or marker of atherosclerosis?

Problems with current PAPP-A assays

Future directions


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina
Ahmad A. Elesber, Cheryl A. Conover, Ali E. Denktas, Ryan J. Lennon, David R. Holmes, Jr, Michael T. Overgaard, Michael Christiansen, Claus Oxvig, Lilach O. Lerman, and Amir Lerman
EHJ 2006 27: 1678-1684. [Abstract] [FREE Full Text]